Shefer A, Lewis B S, Gang E S
Cardiology Department, Ichilov Medical Center, Tel-Aviv, Israel.
Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 1):1646-51. doi: 10.1111/j.1540-8159.1996.tb03194.x.
This report describes a percutaneous, transaxillary approach for implanting permanent pacemakers in the retropectoral space. This approach was used in 17 patients; indications for the procedure included the need to find a new implantation site in patients with infections and multiple previous pacemaker pocket sites (2 patients), emaciation and absence of sufficient adipose tissue (4 patients), and cosmetic considerations (11 patients). No complications were encountered during the implantation and the results were uniformly excellent in all patients. The pacemaker was "invisible" in each case. We conclude that a percutaneous approach for implanting permanent pacemakers in the retropectoral region is safe and feasible. This approach is likely to be applicable to the implantation of transvenous antitachycardia devices.
本报告描述了一种经皮经腋窝途径在胸后间隙植入永久性起搏器的方法。该方法应用于17例患者；手术适应证包括感染患者及既往有多个起搏器囊袋部位需寻找新植入部位（2例）、消瘦且缺乏足够脂肪组织（4例）以及出于美观考虑（11例）。植入过程中未出现并发症，所有患者的结果均一致良好。在每种情况下，起搏器均“不可见”。我们得出结论，经皮途径在胸后区域植入永久性起搏器是安全可行的。该方法可能适用于经静脉抗心动过速装置的植入。
